Liver Cirrhosis
📧 Sign up to get email alerts when something new happens for Liver Cirrhosis.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2025-01-20EMA Revoked: Ocaliva (obeticholic acid) — Advanz Pharma Limited
EMA revoked the marketing authorization for Ocaliva (obeticholic acid) held by Advanz Pharma Limited, effective 16 April 2024, for biliary/l…
-
CLINICAL_TRIALS withdrawal · 2022-02-08Clinical Trial Update: Rifaximin Versus Lactulose in Renal Failure [Phase 4]
Phase 4 trial comparing rifaximin to lactulose in patients with liver cirrhosis and renal failure was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-06-14Clinical Trial Update: Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis [Phase 4]
A Phase 4 trial evaluating fresh frozen plasma as a substitute for albumin in patients undergoing large volume paracentesis has been withdra…
-
CLINICAL_TRIALS withdrawal · 2019-02-15Clinical Trial Update: Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure [Phase 2]
A Phase 2 trial evaluating whether midodrine, octreotide, and albumin can improve renal function in patients with liver cirrhosis and renal …
-
CLINICAL_TRIALS withdrawal · 2018-07-17Clinical Trial Update: The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study) [NA]
The LTX-Stent Study investigating the influence of cirrhosis of the liver on coronary restenosis has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2018-06-26Clinical Trial Update: Impact of Acute Decompensation in Patients of Cirrhosis With or Without Prior Decompensation
A clinical trial (NCT03005587) assessing the impact of acute decompensation in patients with liver cirrhosis, with or without prior decompen…
-
CLINICAL_TRIALS withdrawal · 2018-06-06Clinical Trial Update: Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of Liver [NA]
A clinical trial evaluating acenocoumarol for portal vein thrombosis in liver cirrhosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-02-15Clinical Trial Update: Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis [NA]
The clinical trial evaluating anticoagulation for non-occlusive portal vein thrombosis in patients with liver cirrhosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-08-13Clinical Trial Update: Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371) [Phase 3]
Phase 3 trial evaluating low-dose maintenance peginterferon alfa-2b versus supportive care in patients with cirrhotic hepatitis C and HIV ha…
-
CLINICAL_TRIALS withdrawal · 2014-01-28Clinical Trial Update: Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver
A clinical trial evaluating gadoxetic acid-enhanced MRI for hepatocellular carcinoma and dysplastic nodules in cirrhotic liver has been with…